🏥 治験ポータル
← 治験一覧に戻る

国際ギラン・バレー症候群転帰研究

基本情報

NCT ID
NCT01582763
ステータス
完了
試験のフェーズ
-
試験タイプ
観察
目標被験者数
2,000
治験依頼者名
Erasmus Medical Center

概要

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.

対象疾患

Guillain-Barré SyndromeMiller Fisher Syndrome

依頼者(Sponsor)

実施施設 (9)

National Defense Medical College

Tokorozawa, Japan

Dokkyo Medical Univeristy

Tochigi, Japan

近畿大学病院

Osaka, Japan

Toho University Medical Center

Tokyo, Japan

Dokkyo Medical Univeristy

Tochigi, Japan

Toho University Medical Center

Tokyo, Japan

National Defense Medical College

Tokorozawa, Japan

北海道大学病院

Sapporo, Japan

千葉大学医学部附属病院

Chiba, Japan